February 3, 2023
NOT-OD-23-008 - RESCINDED - Clarification and Guidance for Applicants Preparing Applications for the FALL 2022 Due Dates During the COVID-19 Pandemic
NOT-OD-22-112 - RESCINDED - Clarification and Guidance for Applicants Preparing Applications for the Summer 2022 Due Dates During the COVID-19 Pandemic
NOT-OD-22-046 - RESCINDED - Clarification and Guidance for Applicants Preparing Applications for the Spring 2022 Due Dates During the COVID-19 Pandemic
NOT-OD-21-180 - RESCINDED -Clarification and Guidance for Applicants Preparing Applications for the Fall 2021 Due Dates During the COVID-19 Pandemic
NATIONAL INSTITUTES OF HEALTH (NIH)
The NIH remains firmly committed to supporting the biomedical research enterprise as the nation implements the President's Guidelines for Re-Opening America Again. The purpose of this Notice is to extend the guidance provided earlier (NOT-OD-23-008) for applicants preparing applications for the August/October 2023 Council round, beginning with the January 25, 2023 due date.
Reviewers will continue to receive instructions to assume that constraints arising from the COVID-19 pandemic (e.g., lab occupancy restrictions, declines in patient accrual, etc.) will be resolved during the project period and thus should not affect their scores.
Therefore, NIH grant applications should NOT include contingency or recovery plans for problems resulting from the COVID-19 pandemic. However, applicants may address effects due to the pandemic on productivity or other scoreable issues in their Personal Statement in the NIH Biosketch. Reviewers will be instructed to take these pandemic-related circumstances into account when assessing applicants' productivity and other score-driving factors.
As with previous instructions, if needed, NIH staff will request and assess plans to resolve specific problems arising from the COVID-19 pandemic prior to funding.
Inquiries
Please direct all inquiries to:
NIH Review Policy Officer
Email: ReviewPolicyOfficer@mail.nih.gov
and Human Services (HHS)
